Pazopanib HCl

inquiry

Cat No.

CEI-0009

Description

Alias

GW786034

CAS_No

635702-64-6

Molecular Weight

473.98

Purity

>99%

Storage

2 years at -20 centigrade

Synonyms

GW786034

Targets

VEGFR1, VEGFR2, VEGFR3

Molecular Formula

C21H23N7O2S.HCl

Chemical Name

5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide hydrochloride

Solubility

DSMO 70 mg/mL Water 17 mg/mL Ethanol

In vitro

Pazopanib (GW786034B; GlaxoSmithKline) is a novel multi-targeted, orally available, small-molecule tyrosine kinase inhibitor of VEGF receptor 1, VEGF receptor 2, and VEGF receptor 3 with IC50 values of 10 nM, 30 nM, and 47 nM. Pazopanib (GW786034B; GlaxoSmithKline) also shows inhibition to platelet-derived growth factor receptor (including PDGFR-alpha and PDGFR-beta), and c-kit, FGF-R1, and c-fms with IC50 of 84, 74, 140, and 146 nM. Pazopanib can inhibit MM cell growth, survival, and migration. It can inhibit MM cell lines including dexamethasone-sensitive MM.1S, dexamethasone resistant MM.1R, doxorubicin (Dox)-sensitive RPMI, Dox-resistant RPMI (Dox40), IL-6-dependent INA-6, OPM2, and U266. Pazopanib suppresses VEGF-Induced Endothelial Cell Proliferation and Migration.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry